AstraZeneca’s COVID-19 vaccine offers stronger immunity with 45-week gap between doses, company says
A longer, 10-month delay in administering second doses of AstraZeneca’s COVID-19 vaccine afforded trial participants stronger immunity, the company announced Monday, aiming to assuage concerns of compromised immunity among populations of countries with short vaccine supply. Researchers with the University of Oxford posted findings on The Lancet’s preprint server Monday, drawing from trial participants aged… Read More »